Cited by 99Bariatric Surgery and OutcomesDiabetes Treatment and ManagementDiabetes Management and Research

GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: A potential new indication?

Abrahamsson, Niclas, Engström, Britt Edén, Sundbom, Magnus, Karlsson, F Anders·2013·European Journal of Endocrinology

Abstract

OBJECTIVE: The number of morbidly obese subjects submitted to bariatric surgery is rising worldwide. In a fraction of patients undergoing gastric bypass (GBP), episodes with late postprandial hypoglycemia (PPHG) develop 1-3 years after surgery. The pathogenesis of this phenomenon is not fully understood; meal-induced rapid and exaggerated increases of circulating incretins and insulin appear to be at least partially responsible. Current treatments include low-carbohydrate diets, inhibition of glucose intestinal uptake, reduction of insulin secretion with calcium channel blockers, somatostatin analogs, or diazoxide, a KATP channel opener. Even partial pancreatectomy has been advocated. In type 2 diabetes, GLP1 analogs have a well-documented effect of stabilizing glucose levels without causing hypoglycemia. DESIGN: We explored GLP1 analogs as open treatment in five consecutive GBP cases seeking medical attention because of late postprandial hypoglycemic symptoms. RESULTS: Glucose measured in connection with the episodes in four of the cases had been 2.7, 2.5, 1.8, and 1.6 mmol/l respectively. The patients consistently described that the analogs eliminated their symptoms, which relapsed in four of the five patients when treatment was reduced/discontinued. The drug effect was further documented in one case by repeated 24-h continuous glucose measurements. CONCLUSION: These open, uncontrolled observations suggest that GLP1 analogs might provide a new treatment option in patients with problems of late PPHG.

Integrity signals

Registry

Crossref · 10.1530/eje-13-0504

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abrahamsson, N., Engström, B. E., Sundbom, M., & Karlsson, F. A.
Affiliations
  • University Hospital (CA)
  • Uppsala University (SE)
Corresponding author
Karlsson, F Anders
Venue
European Journal of Endocrinology
Published
2013-12
Volume
169
Issue
6
Pages
885-889
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2168804523
Cited by
99
References
24
Citations by year
2026: 6 · 2025: 6 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 8 · 2020: 12 · 2019: 10 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 3
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
GLP-1 receptor agonists, postprandial hypoglycemia, gastric bypass, bariatric surgery complications, morbid obesity, incretins, insulin secretion, type 2 diabetes, continuous glucose monitoring, new drug indications
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemia, Male, Middle Aged, Obesity, Morbid, Gastric Bypass, Treatment Outcome, Postprandial Period, Glucagon-Like Peptide 1, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review